01.) Piva JP, Garcia PC, Carvalho PR, Luchese S. Síndrome do desconforto (angústia) respiratório agudo (SDRA/SARA). In: Piva JP, Carvalho PR, Garcia PC (eds). Terapia intensiva em pediatria. 4ª. ed. Rio de Janeiro: Medsi, 1997: 176-96.

02.) Slutsky AS. Lung injury caused by mechanical ventilation. Chest 1999;116 (1 Suppl):9S-15S.

03.) Slutsky AS. Lung injury caused by mechanical ventilation. Chest 1999;116 (1 Suppl):9S-15S.

04.) Ranieri VM, Slutsky AS. Respiratory physiology and acute lung injury: the miracle of Lazarus. Intensive Care Med 1999; 25(10): 1040-3.

05.) Clark RH, Slutsky AS, Gerstmann DR. Lung protective strategies of ventilation in the neonate: what are they? Pediatrics 2000; 105(1 Pt 1): 112-4.

06.) Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 1998; 157(1): 294-323.

07.) Creamer KM, McCloud LL, Fisher LE, Ehrhart IC. Closing pressure rather than opening pressure determines optimal positive end-expiratory pressure and avoids overdistention. Chest 1999; 116(1 Suppl): 26S-27S.

08.) Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, et al. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338(6): 347-54.

09.) The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342(18): 1301-8.

10.) Taskar V, John J, Evander E, Robertson B, Jonson B. Surfactant dysfunction makes lungs vulnerable to repetitive collapse and reexpansion. Am J Respir Crit Care Med 1997; 155(1): 313-20.

11.) Kolton M, Cattran CB, Kent G, Volgyesi G, Froese AB, Bryan AC. Oxygenation during high-frequency ventilation compared with conventional mechanical ventilation in two models of lung injury. Anesth Analg 1982; 61(4): 323-32.

12.) Froese AB, McCulloch PR, Sugiura M, Vaclavik S, Possmayer F, Moller F. Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit. Am Rev Respir Dis 1993; 148(3): 569-77.

13.) Doctor A, Arnold J. Mechanical support of acute lung injury: options for strategic ventilations. New Horizons 1999; 7: 359-73.

14.) Ito Y, Manwell SE, Kerr CL, Veldhuizen RA, Yao LJ, Bjarneson D, et al. Effects of ventilation strategies on the efficacy of exogenous surfactant therapy in a rabbit model of acute lung injury. Am J Respir Crit Care Med 1998; 157 (1): 149-55.

15.) Ito Y, Veldhuizen RA, Yao LJ, McCaig LA, Bartlett AJ, Lewis JF. Ventilation strategies affect surfactant aggregate conversion in acute lung injury. Am J Respir Crit Care Med 1997; 155(2): 493-9.

16.) Hatcher D, Watanabe H, Ashbury T, Vincent S, Fisher J, Froese A. Mechanical performance of clinically available, neonatal, high-frequency, oscillatory-type ventilators. Crit Care Med 1998; 26(6): 1081-8.

17.) McCulloch PR, Forkert PG, Froese AB. Lung volume maintenance prevents lung injury during high frequency oscillatory ventilation in surfactant-deficient rabbits. Am Rev Respir Dis 1988; 137(5): 1185-92.

18.) Thome U, Topfer A, Schaller P, Pohlandt F. Effects of mean airway pressure on lung volume during high-frequency oscillatory ventilation of preterm infants. Am J Respir Crit Care Med 1998; 157(4 Pt 1): 1213-8

19.) Meredith KS, deLemos RA, Coalson JJ, King RJ, Gerstmann DR, Kumar R, et al. Role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons. J Appl Physiol 1989; 66(5): 2150-8.

20.) Hamilton PP, Onayemi A, Smyth JA, Gillan JE, Cutz E, Froese AB, et al. Comparison of conventional and high- frequency ventilation: oxygenation and lung pathology. J Appl Physiol 1983; 55(1 Pt 1): 131-8.

21.) Takata M, Abe J, Tanaka H, Kitano Y, Doi S, Kohsaka T, et al. Intraalveolar expression of tumor necrosis factor-alpha gene during conventional and high-frequency ventilation. Am J Respir Crit Care Med 1997; 156(1): 272-9.

22.) Cochrane CG, Revak SD. Surfactant lavage treatment in a model of respiratory distress syndrome. Chest 1999; 116(1 Suppl): 85S-86S

23.) Kerr CL, Ito Y, Manwell SE, Veldhuizen RA, Yao LJ, McCaig LA, et al. Effects of surfactant distribution and ventilation strategies on efficacy of exogenous surfactant. J Appl Physiol 1998; 85(2): 676-84.

24.) Bauman LA, Wilson DF. Surfactant in pediatric respiratory failure. New Horizons 1999; 7: 399-413.

25.) Gregory TJ, Steinberg KP, Spragg R, Gadek JE, Hyers TM, Longmore WJ, et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155(4): 1309-15.

26.) Krause MF, Schulte-Monting J, Hoehn T. Rate of surfactant administration influences lung function and gas exchange in a surfactant-deficient rabbit model. Pediatr Pulmonol 1998; 25(3): 196-204.

27.) Hills BA. An alternative view of the role(s) of surfactant and the alveolar model. J Appl Physiol 1999; 87(5): 1567-83.

28.) Kobayashi T, Ohta K, Tashiro K, Nishizuka K, Chen WM, Ohmura S, et al. Dextran restores albumin-inhibited surface activity of pulmonary surfactant extract. J Appl Physiol 1999; 86(6): 1778-84.

29.) William Taeusch H, Lu KW, Goerke J, Clements JA. Non ionic polymers reverse inactivation of surfactant by meconium and other substances. Am J Respir Crit Care Med 1999; 159(5 Pt 1): 1391-5.

30.) Sohma A, Brampton WJ, Dunnill MS, Sykes MK. Effect of ventilation with positive end-expiratory pressure on the development of lung damage in experimental acid aspiration pneumonia in the rabbit. Intensive Care Med 1992; 18(2): 112-7.

31.) Chang HK. Mechanisms of gas transport during ventilation by high-frequency oscillation. J Appl Physiol 1984; 56(3): 553-63.